Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ricks, D M
1977.
Bringing up Disabled Children.
Proceedings of the Royal Society of Medicine,
Vol. 70,
Issue. 1,
p.
28.
Horrobin, D. F.
Ally, A. I.
Karmali, R. A.
Karmazyn, M.
Manku, M. S.
and
Morgan, R. O.
1978.
Prostaglandins and schizophrenia: further discussion of the evidence.
Psychological Medicine,
Vol. 8,
Issue. 1,
p.
43.
Sandler, M.
1978.
The Biological Basis of Schizophrenia.
p.
79.
Whitlock, F. A.
and
Hynes, J. V.
1978.
Religious stigmatization: an historical and psychophysiological enquiry.
Psychological Medicine,
Vol. 8,
Issue. 2,
p.
185.
Falloon, I.
Watt, D. C.
Lubbe, K.
Macdonald, A.
and
Shepherd, Michael
1978.
N-acetyl-p-amino-phenol (paracetamol, acetaminophen) in the treatment of acute schizophrenia.
Psychological Medicine,
Vol. 8,
Issue. 3,
p.
495.
Horrobin, DavidF.
1979.
PROSTAGLANDINS AND SCHIZOPHRENIA.
The Lancet,
Vol. 313,
Issue. 8124,
p.
1031.
Jed Wyatt, Richard
Bigelow, Llewellyn B.
and
Gillin, J. Christian
1979.
Catecholamines: Basic and Clinical Frontiers.
p.
1820.
Dohan, F.C.
1979.
SCHIZOPHRENIA AND NEUROACTIVE PEPTIDES FROM FOOD.
The Lancet,
Vol. 313,
Issue. 8124,
p.
1031.
van Kammen, Daniël P.
and
Sternberg, David E.
1980.
Neurobiology of Cerebrospinal Fluid 1.
p.
719.
Hall, G. H.
1980.
Biochemistry of Schizophrenia and Addiction.
p.
199.
Mathé, A.A.
Wiesel, F.A.
Sedvall, G.
and
Nybäck, H.
1980.
INCREASED CONTENT OF IMMUNOREACTIVE PROSTAGLANDIN E IN CEREBROSPINAL FLUID OF PATIENTS WITH SCHIZOPHRENIA.
The Lancet,
Vol. 315,
Issue. 8158,
p.
16.
Ragheb, Mohamed
and
Ban, Thomas A.
1982.
Prostaglandins and schizophrenia: A review.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 6,
Issue. 2,
p.
87.
Rudin, Donald O.
1982.
The dominant diseases of modernized societies as omega-3 essential fatty acid deficiency syndrome: Substrate beriberi.
Medical Hypotheses,
Vol. 8,
Issue. 1,
p.
17.
Malek-Ahmadi, Parviz
and
Weddle, Margaret A.
1982.
Schizophrenia and prostaglandins: Theories and therapeutic implications.
General Pharmacology: The Vascular System,
Vol. 13,
Issue. 6,
p.
467.
Whalley, L. J.
Reading, H. W.
and
Rosie, R.
1984.
ADP and arachidonic acid induced platelet aggregation in schizophrenia and atypical psychoses.
Psychological Medicine,
Vol. 14,
Issue. 1,
p.
207.
DeLisi, Lynn Eleanor
and
Wyatt, Richard Jed
1985.
Pathological Neurochemistry.
p.
553.
Mathe, Aleksander A.
Eberhard, Göran
Sääf, Jan
and
Wetterberg, Lennart
1986.
Plasma prostaglandin E2 metabolite—measured as 11 -deoxy-15 -keto-13,14-dihydro-11 β, 16ξ-cyclo-PGE2—in twins with schizophrenic disorder.
Biological Psychiatry,
Vol. 21,
Issue. 11,
p.
1024.
Wilson, Donald W.S.
and
Douglass, Alan B.
1986.
Niacin skin flush is not diagnostic of schizophrenia.
Biological Psychiatry,
Vol. 21,
Issue. 10,
p.
974.
Horrobin, David F.
1987.
Essential Fatty Acids, Prostaglandins, and Alcoholism: An Overview.
Alcoholism: Clinical and Experimental Research,
Vol. 11,
Issue. 1,
p.
2.
Yeragani, V.K.
and
Chaitin, P.
1987.
A prostaglandin theory of neuroleptic malignant syndrome.
Medical Hypotheses,
Vol. 24,
Issue. 2,
p.
143.